H. P. Gurtner

487 total citations
22 papers, 354 citations indexed

About

H. P. Gurtner is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, H. P. Gurtner has authored 22 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in H. P. Gurtner's work include Nitric Oxide and Endothelin Effects (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Cardiac Imaging and Diagnostics (3 papers). H. P. Gurtner is often cited by papers focused on Nitric Oxide and Endothelin Effects (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Cardiac Imaging and Diagnostics (3 papers). H. P. Gurtner collaborates with scholars based in Switzerland, United States and Austria. H. P. Gurtner's co-authors include A. Prader, R Mordasini, Walter F. Riesen, U Althaus, Bernard A. Roos, Steven A. Hamburger, A. Cournand, W. A. Briscoe, Hugo Saner and Bengt Kayser and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Applied Physiology and Atherosclerosis.

In The Last Decade

H. P. Gurtner

20 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. P. Gurtner Switzerland 9 128 123 117 71 38 22 354
B. Greg Brown United States 10 75 0.6× 197 1.6× 182 1.6× 51 0.7× 24 0.6× 15 409
Y Yamaguchi Japan 11 78 0.6× 92 0.7× 89 0.8× 50 0.7× 28 0.7× 46 410
M. Farrer United Kingdom 14 178 1.4× 181 1.5× 136 1.2× 52 0.7× 66 1.7× 27 464
Warnet Jm France 5 301 2.4× 56 0.5× 210 1.8× 98 1.4× 67 1.8× 15 467
H. Ditschuneit Germany 16 161 1.3× 407 3.3× 102 0.9× 118 1.7× 134 3.5× 58 801
A. Anderson United States 7 75 0.6× 134 1.1× 106 0.9× 59 0.8× 43 1.1× 17 383
Harry Yu United States 8 84 0.7× 124 1.0× 96 0.8× 48 0.7× 132 3.5× 9 373
Ping‐sheng Wu China 11 82 0.6× 66 0.5× 92 0.8× 89 1.3× 61 1.6× 28 363
Sue E. Poulin United States 7 36 0.3× 105 0.9× 68 0.6× 91 1.3× 135 3.6× 10 410
Richard P. Saik United States 10 36 0.3× 265 2.2× 81 0.7× 34 0.5× 52 1.4× 34 467

Countries citing papers authored by H. P. Gurtner

Since Specialization
Citations

This map shows the geographic impact of H. P. Gurtner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. P. Gurtner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. P. Gurtner more than expected).

Fields of papers citing papers by H. P. Gurtner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. P. Gurtner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. P. Gurtner. The network helps show where H. P. Gurtner may publish in the future.

Co-authorship network of co-authors of H. P. Gurtner

This figure shows the co-authorship network connecting the top 25 collaborators of H. P. Gurtner. A scholar is included among the top collaborators of H. P. Gurtner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. P. Gurtner. H. P. Gurtner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Duncan L., Hans Hoppeler, H. P. Gurtner, et al.. (1993). Limitations to VO2max in humans after blood retransfusion. Respiration Physiology. 92(3). 329–341. 31 indexed citations
2.
Gurtner, H. P., et al.. (1993). [Aminorex-induced, plexogenic pulmonary arteriopathy: 25 years later!].. PubMed. 82(9). 568–72. 6 indexed citations
3.
Allemann, Yves, et al.. (1992). Left ventricular structure and determinants in normotensive offspring of essential hypertensive parents. Journal of Hypertension. 10(10). 1257–1264. 13 indexed citations
4.
Liechti, Matthias E., et al.. (1990). [Cardiac complications of American trypanosomiasis (Chagas disease). Various case reports and general observations].. PubMed. 120(41). 1493–6. 8 indexed citations
6.
Althaus, U, et al.. (1986). Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. Clinical Cardiology. 9(4). 157–160. 1 indexed citations
7.
Saner, Hugo, H. P. Gurtner, R Preisig, & A Küpfer. (1986). Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate. European Journal of Clinical Pharmacology. 31(4). 437–442. 6 indexed citations
8.
Althaus, U, et al.. (1984). Influence of Sulfinpyrazone on Infarct Size, Hemodynamics, and Arrhythmia Following Coronary Occlusion in the Pig. Journal of Cardiovascular Pharmacology. 6(5). 829–832. 3 indexed citations
9.
Gurtner, H. P., et al.. (1981). [Staying at high altitudes and plane travel for heart patients].. PubMed. 111(18). 618–24. 1 indexed citations
10.
Riesen, Walter F., et al.. (1980). Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis. 37(1). 157–162. 122 indexed citations
11.
Althaus, U, et al.. (1977). Consequences of myocardial reperfusion following temporary coronary occlusion in pigs: effects on morphologic, biochemical and haemodynamic findings. European Journal of Clinical Investigation. 7(5). 437–443. 44 indexed citations
12.
Bachofen, H, H. P. Gurtner, & G. Paumgartner. (1973). Mixed venous-arterial difference of molecular nitrogen in man.. Journal of Applied Physiology. 35(6). 791–792.
13.
Gurtner, H. P., et al.. (1968). [Are the primary vascular forms of chronic pulmonary heart disease becoming more common?].. PubMed. 98(41). 1579–707. 25 indexed citations
14.
Gurtner, H. P., et al.. (1965). Zur korrigierten Transposition der großen Gefäße. Cardiology. 46(3). 165–172.
15.
Gurtner, H. P., et al.. (1962). Acute Systeinic and Coronary Hemodynamic Effects of Trimethidinium Methosulfate.. Experimental Biology and Medicine. 110(1). 74–77. 2 indexed citations
16.
Gurtner, H. P.. (1961). [Aneurin and nerve stimulation experiments with S35-labelled aneurin and aneurin metabolites].. PubMed. Suppl 11. 1–48. 1 indexed citations
18.
Gurtner, H. P.. (1958). Untersuchungen �ber die Wirkung der Aneurinantimetaboliten Neopyrithiamin und Oxythiamin auf den anticholinergischen Effekt von Aneurin am isolierten Froschherzen. Pflügers Archiv - European Journal of Physiology. 265(5). 423–428. 1 indexed citations
19.
Otsuka, Masakazu & H. P. Gurtner. (1957). [Resting potential, threshold potential, and action potential of single myocardial fibers in aneurin deficient rats].. PubMed. 15(4). C 73–5. 1 indexed citations
20.
Prader, A. & H. P. Gurtner. (1955). [The syndrome of male pseudohermaphrodism in congenital adrenocortical hyperplasia without overproduction of androgens (adrenal male pseudohermaphrodism)].. PubMed. 10(4). 397–412. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026